Logo

drug

Treating a mass

India is about to test a radical idea: can a country known as the world’s pharmacy also become its slimming clinic? The imminent arrival of low-cost versions of semaglutide ~ marketed globally as Wegovy and Ozempic by Novo Nordisk ~ could turn a once-exclusive therapy into a mass-consumption drug.